Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Youfu Li

Showing results (61-70 of 69) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 69 results.
Journal of Vascular Surgery|November 28, 2012
Derivation and validation of a practical risk score for prediction of mortality after open repair of ruptured abdominal aortic aneurysms in a US regional cohort and comparison to existing scoring systemsWilliam P Robinson, Andres Schanzer, Youfu Li, et al.
Journal of the American College of Nutrition|April 4, 2006
Association between carbohydrate intake and serum lipidsYunsheng Ma, Youfu Li, David E Chiriboga, et al.
Circulation|December 10, 2009
Association of cyclooxygenase-1-dependent and -independent platelet function assays with adverse clinical outcomes in aspirin-treated patients presenting for cardiac catheterizationAndrew L Frelinger, YouFu Li, Matthew D Linden, et al.
Plos One|April 12, 2014
Antiplatelet activity, P2Y₁ and P2Y₁₂ inhibition, and metabolism in plasma of stereoisomers of diadenosine 5',5'″-P¹ ,P⁴-dithio-P²,P³-chloromethylenetetraphosphateHung Chang, Ivan B Yanachkov, Edward J Dix, et al.
Rheumatology and Therapy|September 23, 2017
Impact of Tocilizumab Monotherapy on Clinical and Patient-Reported Quality-of-Life Outcomes in Patients with Rheumatoid ArthritisLeslie R Harrold, Ani John, George W Reed, et al.
Blood|February 2, 2012
In vivo effects of eltrombopag on platelet function in immune thrombocytopenia: no evidence of platelet activationBethan Psaila, James B Bussel, Matthew D Linden, et al.
Thrombosis and Haemostasis|June 29, 2007
The active metabolite of prasugrel inhibits ADP-stimulated thrombo-inflammatory markers of platelet activation: Influence of other blood cells, calcium, and aspirinAndrew L Frelinger, Joseph A Jakubowski, Youfu Li, et al.
American Health & Drug Benefits|June 19, 2018
Delayed Treatment Acceleration in Patients with Rheumatoid Arthritis Who Have Inadequate Response to Initial Tumor Necrosis Factor Inhibitors: Data from the Corrona RegistryDimitrios A Pappas, Robert A Gerber, Heather J Litman, et al.
European Heart Journal|May 14, 2009
Pharmacodynamic assessment of platelet inhibition by prasugrel vs. clopidogrel in the TRITON-TIMI 38 trialAlan D Michelson, Andrew L Frelinger, Eugene Braunwald, et al.
Pageof 7

Showing results (61-70 of 69) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 69 results.
Journal of Vascular Surgery|November 28, 2012
Derivation and validation of a practical risk score for prediction of mortality after open repair of ruptured abdominal aortic aneurysms in a US regional cohort and comparison to existing scoring systemsWilliam P Robinson, Andres Schanzer, Youfu Li, et al.
Journal of the American College of Nutrition|April 4, 2006
Association between carbohydrate intake and serum lipidsYunsheng Ma, Youfu Li, David E Chiriboga, et al.
Circulation|December 10, 2009
Association of cyclooxygenase-1-dependent and -independent platelet function assays with adverse clinical outcomes in aspirin-treated patients presenting for cardiac catheterizationAndrew L Frelinger, YouFu Li, Matthew D Linden, et al.
Plos One|April 12, 2014
Antiplatelet activity, P2Y₁ and P2Y₁₂ inhibition, and metabolism in plasma of stereoisomers of diadenosine 5',5'″-P¹ ,P⁴-dithio-P²,P³-chloromethylenetetraphosphateHung Chang, Ivan B Yanachkov, Edward J Dix, et al.
Rheumatology and Therapy|September 23, 2017
Impact of Tocilizumab Monotherapy on Clinical and Patient-Reported Quality-of-Life Outcomes in Patients with Rheumatoid ArthritisLeslie R Harrold, Ani John, George W Reed, et al.
Blood|February 2, 2012
In vivo effects of eltrombopag on platelet function in immune thrombocytopenia: no evidence of platelet activationBethan Psaila, James B Bussel, Matthew D Linden, et al.
Thrombosis and Haemostasis|June 29, 2007
The active metabolite of prasugrel inhibits ADP-stimulated thrombo-inflammatory markers of platelet activation: Influence of other blood cells, calcium, and aspirinAndrew L Frelinger, Joseph A Jakubowski, Youfu Li, et al.
American Health & Drug Benefits|June 19, 2018
Delayed Treatment Acceleration in Patients with Rheumatoid Arthritis Who Have Inadequate Response to Initial Tumor Necrosis Factor Inhibitors: Data from the Corrona RegistryDimitrios A Pappas, Robert A Gerber, Heather J Litman, et al.
European Heart Journal|May 14, 2009
Pharmacodynamic assessment of platelet inhibition by prasugrel vs. clopidogrel in the TRITON-TIMI 38 trialAlan D Michelson, Andrew L Frelinger, Eugene Braunwald, et al.
Pageof 7